Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PRN Pharmacal is a specialty veterinary pharmaceutical company that develops, manufactures, and markets niche health products for the animal health industry. A brand of Pegasus Laboratories and a subsidiary of PBI-Gordon Corporation, the company is best known for its flagship product Proin, used to manage urinary incontinence in dogs. Their portfolio spans a wide range of therapeutic areas including urology, dermatology, and nutritional supplements for both companion animals and livestock. PRN Pharmacal operates out of a cGMP-compliant facility in Pensacola, Florida, where it also provides contract manufacturing services. The company focuses on providing veterinarians with effective solutions for conditions that are often underserved by larger pharmaceutical firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PRN Pharmacal.